脑部放疗，上午比下午敏感许多！6 C" a4 `; f( j" m0 x
6 Q; L3 k6 t$ z0 g% s2 d# x
7 G6 ]$ J0 q5 Q) j3 I7 g1 ?
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
+ C1 ]9 p$ }2 I0 e0 z5 W% |: rGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
R% _/ k/ v4 [8 R# c; @Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.( |" J3 Z0 g0 I# |' e
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
- X/ Z- M3 e! S
6 @8 X5 X) J9 w' h( W; j# f5 vAbstract
- O S+ T/ h; d/ {" y! q* nBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.( _9 s* }* K' F
2 t- a% z; s1 Q) K/ n
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.; f3 y! g4 g' K0 z' q9 x
: n/ g8 ^& w5 j8 d0 B: f0 k
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
- p* ^- f1 x% z/ l0 a7 `
; P" y# c, \' m$ D8 f1 vCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
2 u; Y( C: g" A) I8 i4 r, d; \! A6 a# [
* \3 Z" V% V7 W( T0 g. u$ a( v. M |
显身卡
